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Abstract
Purpose: Traditionally, lead and Cerrobend have been employed for field shapingin radiation therapy. Lately, another shielding material called Gamma Putty hasemerged. The objective of this report is to examine its dosimetric and shieldingcharacteristics in megavoltage photon beam. Methods: All measurements werecarried out in a dual energy linac. Data were collected using a calibrated ionizationchamber. Percent transmission, linear attenuation, and field size dependence wereevaluated for open square fields (4 × 4 cm2 to 10 × 10 cm2) defined by collimatorjaws and for different Gamma Putty thicknesses (t = 0, 0.3, 0.5, 1.0, 1.5, 2.0, and 2.5cm) at 6 and 18 MV photon beams. The measurements were performed both in airusing appropriate acrylic buildup cap and in solid water. Results: The GammaPutty tray factor (GPTF) increased steadily with field size for both 6 and 18 MV. Itwas characterized by a half value thickness (HVT) of 2.513 ± 0.101 and 2.855 ±0.024 cm for 6 and 18 MV, respectively. The reduction in surface dose was about6%, 14.5%, 22%, 36.37%, and 54% for 6 MV and 2.75 %, 9.36 %, 16.25 %, 28.95 %,and 44.47 % for 18 MV for Gamma Putty thicknesses of 0.3, 0.5, 1.0, 1.5, 2.0, and 2.5cm. Conclusion: The result of Gamma Putty shielding on the photon beam outputincreases with thickness, beam energy, and field size. Therefore, clinical use ofGamma Putty tray factors should be tailored for all thicknesses, beam energies, andfield sizes.
Keywords: Gamma Putty, Tray factor, Linear attenuation, Surface dose.
1. IntroductionThe purpose of radiotherapy treatment is to deliver doseto the tumor and curtail dose to the surrounding normaltissue by sometimes using beam modifiers. Based onseveral reports, Lead and cerrobend blocks have beencommonly and predominantly used.1,2 Several authorshave described a wide range use of block applications.Purdy et al.3 used a gonadal shield based cerrobend inthe pelvic irradiation of males to reduce the gonadaldose to about1.5 – 2.5% of the given dose. Sohn et al.4employed a mobile shield to decrease the scatter dose tothe contralateral breast from the linear accelerator by afactor of 3 to 4. In the head and neck treatmentradiation, stents were utilized to protect healthytissues,5, 6 whereas in the mantle instance, MLC leaveswere moved in or out to get the required shape in somecases.7Nevertheless, these shielding blocks cannot alwaysconform exactly to the patient anatomy and region ofinterest. They experienced variable thicknessconsistency and are hard to plan and align effectively onthe patient. To maximize a good shielding material, some
properties are desirable. They included high atomicnumber and attenuation coefficient so as to absorb aradiation, and a low melting point. The shieldingmaterial must be malleable for better conformity,inexpensive, and easily disposable for environmentconcerns. Recently, a material called Gamma Putty thathas been used in the industrial setting for differentpurposes such as shielding cable tray penetrationsaround pipes and radiographic film masking to preventradiation scatter has been wooing as an alternative forlead and cerrobend for many reasons. The Putty is leadfree, malleable, reusable, and can be thinned, thickened,reshaped to follow patient anatomy. As soon as, thewanted shield is made and wrapped in plastic, it can beused for the whole treatment schedule. Furthermore,when treating small lesions electron cutouts are oftenused to shape the beam to the tumor and sparing normaltissue surrounding the tumor. The drawback of using acutout is that the field size is smaller and to some extentinadequate for treatment, resulting in under dosage oflateral tissues. Several important dosimetric parametersfor controlling the dose at extended distances, such as
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the percent depth dose, flatness, penumbra, anduniformity, are greatly affected. In addition, a slightoffset of the field can also result in a large dosedisplacement from the region of interest. These factshave been emphasized by several studies.1,2,3,4 Again,from dosimetric perspective lead or cerrobend arebelieved to be a better skin collimator. However, GammaPutty as a skin collimator is more easily fabricated andrequired no specific tools than lead or Cerrobend. Thegoal of this study is to evaluate the dosimetric andshielding properties of Gamma Putty in megavoltageradiation therapy. The clinical motivation of this study ismany folds:
1.1. PotentialIn this report the effects of Gamma Putty shieldingblocks on incident photon beams of 6 and 18 MVenergies were examined and its clinical potential inradiotherapy evaluated. Gamma Putty could be anadditional arsenal in beam shaping and shielding ofhealthy tissues surrounding the tumor site.
1.2. CharacteristicsIn short, Gamma Putty is a non-hardening material thathas been used during nuclear reactor maintenance astemporary gamma radiation shielding. It is non-toxic,malleable, and readily available commercially. It is verypliable and yet has enough consistency to hold its shapeafter placement. The material can be reused for manyradiotherapy sessions and is environmentally friendlysince it is Lead free. It necessitates no special tools ortechniques to create patient shields and easier to adaptto patient body contour. It is loaded with 90 % bismuthwith high atomic number (Z = 83), thereby useful toshield critical structures as suggested by severalreports,8,9,10 arguing for the shielding properties of highZ materials.
1.3. Clinical applicationsThe potential clinical application of Gamma Putty istremendous. From small field ranging from tip of thenose to eye lesion, it could be broaden to include largefields that accommodate the protection of intraoral headand neck sites, lungs in the case of Mantle field forHodgkin's disease, and kidneys for total bodyirradiation. However, further study is required to assessthe dose distribution behind the protected area, as wellas tailoring Gamma Putty thickness for individual cases.
2. Methods and MaterialsThe Gamma Putty (shieldwerx, Rio Rancho, New Mexico,USA) shielding blocks were produced from Iron polyputty (LDPE) loaded with 90% of Bismuth and a highhydrogen content gear to slow fast neutrons to thermalneutrons with a density of 3.8 g/cc. In this study, theGamma Putty blocks were in circular shapes withdifferent thicknesses. They were mounted on theblocking tray at 67.2 cm distance from source target of
the Trilogy ((Varian Medical systems, Palo Alto, USA)delivering both 6 and 18 MV photon beams.
2.1. Gamma Putty tray factors (GPTF)A photon attenuation characteristic of Gamma Putty wasassessed for 6 and 18 MV megavoltage photon beamsusing variable field sizes (4 × 4, 5 × 5, 6 × 6, 8 × 8, 9 × 9,and 10 × 10 cm2) and normalized to a 10 × 10 cm2 fieldsize. A PTW Farmer chamber of 0.6 cc (PTW Freiburg,Germany) chamber was placed in air to evaluate GPTF.The charge was collected by the ionization chamber andwas measured with an electrometer Model 206 (CNMC,Nashville, TN, USA) using a bias potential of to -300 Vacross the chamber. All measurements were performedwith the detector set isocentrically and perpendicular tocentral axis of the beam. Two acrylic build up caps withdiameter 1.3 cm and 3.5 cm were used for 6 and 18 MVphoton beams respectively. The thickness of thebuild-up cap in each case was sufficiently large enoughto provide maximum dose at the chamber. The radiationtransmission factor of Gamma Putty (GPTF) is definedhere as the ratio of the charge measured with andwithout Gamma Putty in the beam, for the same numberof monitor units:
    fcdD
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where, c is the collimator opening and distance from thesource (f).
2.2. Percent ionization depth measurementIn order to evaluate change of depth dose distribution bythe Gamma Putty, percentage ionization depths weremeasured for several Gamma Putty thicknesses (0.3, 0.5,1.0, 1.5, 2.0, and 2.5 cm). Thus, analyzing the dosimetricimpact of beam are hardening, softening, scattering, andelectron contamination. The measurements wereperformed in solid water Model 458 (CNMC, Nashville,TN, USA). The field size was 10 × 10 cm2, and the sourceto surface distance (SSD) was set at 100 cm. 100monitors unit (MU) were given each time.
2.3. Linear attenuation coefficient determinationThe linear attenuation coefficients value was measuredat 6 and 18 MV photon beams via a Farmer typeionization chamber. These were performed variable fieldsizes (4 × 4, 5 × 5, 6 × 6, 8 × 8, 9 × 9, and 10 × 10 cm2)moderated by Gamma Putty with thickness of (0.3, 0.5,1.0, 1.5, 2.0, 2.5 cm) placed on accessory tray andperformed in air with appropriate buildup cap to reducethe impact of phantom scatter.
3. Results and Discussion
3.1. Gamma Putty BlocksIn this study, the effect of Gamma Putty shielding blockon relative dose in various field sizes and thicknesses
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were analyzed. Six blocks of variable thicknesses (0.3,0.5, 1.0, 1.5, 2.0, and 2.5 cm) were utilized to assess thedose distribution in various field sizes shielded by theGamma Putty (Figures 1a and b). The GPTF as a functionof field size is illustrated in Figures 2a and b for 18 and 6MV photon beam, respectively. GPTF (Tables 1a and b)was generated based on measurements achieved in air
using Farmer type ionization chambers placed on thebeam central axis at the reference depth of dmax in acrylicbuild up caps that provided charged particleequilibrium. The reference depths for 6 and 18 MVphoton beams are 1.3 and 3.5 cm respectively.
Figure 1a: Variable Gamma Putty thickness in a plasticwrap. Figure 1b: Measurement with Gamma Putty on the linacusing a solid water and ion chamber.
Table 1a: Variations of GPTF for 6 MV photon beams as a function of field size and Gamma Putty thickness.Field Size(cm) Gamma Putty thickness (cm)0.3 0.5 1.0 1.5 2.0 2.510 0.874439 0.815503 0.734145 0.661755 0.588085 0.5067269 0.874838 0.817121 0.73476 0.661479 0.588846 0.5058378 0.874016 0.815617 0.733596 0.660105 0.586614 0.5039377 0.874335 0.814495 0.732048 0.65891 0.585106 0.502666 0.874409 0.81499 0.731938 0.657664 0.584065 0.5016885 0.874313 0.81456 0.731456 0.656593 0.583104 0.5006874 0.873603 0.813547 0.729749 0.655726 0.581704 0.499302
Table 1b: Variations of GPTF for 18 MV photon beams as a function of field size and Gamma Putty thickness.Field Size(cm) Gamma Putty thickness (cm)0.3 cm 0.5 cm 1.0 cm 1.5 cm 2.0 cm 2.5 cm10 0.91342 0.85974 0.8 0.707359 0.641558 0.5359319 0.916667 0.859319 0.802867 0.706093 0.641577 0.5331548 0.915663 0.857275 0.802595 0.704356 0.639481 0.530127 0.914587 0.856046 0.801344 0.702495 0.636276 0.5278316 0.91517 0.856287 0.800399 0.702595 0.634731 0.5259485 0.9158 0.856549 0.799376 0.701663 0.634096 0.5249484 0.915767 0.856371 0.798056 0.699784 0.632829 0.523758
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Figures 2a and b shows the GPTF as a function of fieldsize for variable Gamma Putty block thickness for both 6and 18 MV. The figures revealed that GPTF increasessteadily with increasing field size and decreasingGamma Putty thickness for both 6 and 18 MV photonsbeam. This is due to increased scatter contribution, forall Gamma Putty thicknesses at two energies. However,there is a minor GPTF changes as a function of field sizefor the same Gamma Putty thickness, which issystematically higher for 18 MV. The changes at 18 MVincrease with field size and a 50.6% difference wasnoticeable for a 2.5 cm Gamma Putty block. However,behind a block of 0.3 cm thickness, the difference wasevaluated at 12.55%. The trend could be described bylinear regression fits that depended on Gamma Puttythickness as illustrated in Table 2. The observed effectwas perhaps due to the secondary electroncontamination of the photon beam especially at 18 MV.There was a strong relationship between field size andGPTF as Gamma Putty thickness increases. For instance,for 2.5 cm, R2 = 0.997 and 0.963 for 6 and 18 MV,respectively. In fact, dose received by a point in airshielded by Gamma Putty blocks included contributionfrom the primary photon, scattered photons produced,and electron contamination derived from the GammaPutty itself. This effect is enhanced by increasing fieldsize, and energy (18 MV). Also, 90 % of the Gamma Puttyis loaded with Bismuth component of atomic number Z =83. Both attenuation and scattering of the photon beamby the Gamma Putty occurred due to pair production.
Table2: Linear regression R2 for Gamma at variablethicknesses and field sizesThickness (mm) 6 MV 18 MV3 0.404 0.1265 0.634 0.70410 0.903 0.44615 0.988 0.96020 0.950 0.95125 0.997 0.963Figure 3a displayed the measured relative ionizationdepth dose curves in solid water phantom at 18 and 6MV photon beam, respectively for open beam. Similarly,Figures 3b and c illustrated the changes in relativepercent ionization depth dose in solid water for variousGamma Putty thicknesses. This will be translated innotable variation in 18 MV compared to 6 MV. For 6 MV,the curve slopes positions are deeper than the dmax, anddecreased because of the beam hardening effect asGamma Putty thickness increases. For instance, for 2.5cm Gamma Putty thickness, the difference in the relativepercent ionization dose at a depth of 10 cm photons was55.6%, and 58.55% for 6 and 18 MV photons beams,respectively. Furthermore, a small separation of thecurves is noticeable at depths higher than 10 cm,denoting induced Gamma Putty beam hardening. Thesecurves are comparable to the open beam field for both 6and 18 MV. Nevertheless, Figure 3b does not reveal any
effect at depth of Gamma Putty contaminant electrons.Some reports echoed the same results using Cerrobendcompensators on a 6 MV photon beam and suggestedthat compensators do not significantly impact thepercent depth dose characteristics.11,12 On the otherhand, Figure 3c revealed that at 18 MV the Gamma Puttyproduced a beam softening at depth that rises as GammaPutty thickness increased. This is due to pair productionfrom the Gamma Putty. The resulting percent ionizationdecreases at 15cm depth and reaches 50% for the 2.5 cmblock thickness. Conversely at 6 MV, Gamma Puttyaffects the dose in the build-up region indicating thepresence of Gamma Putty scattered photons orcontaminant electrons in the beam.
3.2. Evaluation of the attenuation coefficient of
Gamma PuttyThe effects of radiation beam attenuation for 6 and 18MV photon beam are illustrated in Table 3. The halfvalue thickness (HVT) and Tenth value thickness (TVT)are determined based on an exponential fitting. Anexample is displayed in Figures 4a and b for 10 x 10 cm2field size with a good linear regression coefficient for 6and 18 MV photon beam, respectively. This is translatedby a coefficient of variation of 4.0% and 0.8% for 6 and18 MV, respectively. The difference observed betweenHVT suggested a strong beam energy hardeningdependent. The evaluation of linear attenuationcoefficient in this study is similar to that of Du Plessis et
al. 13
3.3. Evaluation Off-axis relative doseOff-axis relative percent ionization dose profiles areshown in Figures 5a and b for 6 and 18 MV photonbeam, respectively. Only small infield differences, 2% insome instances are accounted for. This difference in outof field photon dose was higher at 18 MV. The increasein percentage skin dose due to the Gamma Putty isgreater at central axis (CAX) with an estimate reductionof 5–10% from the CAX out to the field edge. This may bedue to the lateral scatter of electron contamination fromthe Gamma Putty that supplies a larger amount of doseat the CAX with respect to the off axis areas. This resultis comparable for both 6 and 18 MV but moresignificantly with 2.5cm Gamma Putty thickness at 18MV. The majority of dose deposited at the surfacedirectly under the blocks has been generated by electroncontamination. It was also reported that dose from theblock tray and air to be the main source of skin dose.This effect was dominant in larger field sizes and highenergies. Air between source and skin generatessecondary electrons and these electrons absorbed orscattered in air depended on beam divergence and someof them could reach the patient’s skin. The impact willbecome more prevalent as SSD increased and thenumber of electrons that reach the patient’s skindecreased.14 However, air has more impact than electroncontamination.
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Figure 2a: Gamma Putty Tray factor for different thickness at 18 MV
Figure2b: Gamma Putty Tray factor for different thickness at 6 MV
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Figure 3a: Ionization depth dose curve without Gamma Putty thickness with 6 and 18 MV photon beam at 10 × 10 cm2 field,measured using a Farmer type chamber in solid water phantom.
Figure 3b: Ionization depth dose curve for variable Gamma Putty thicknesses block with 6 MV photon beam at 10 × 10 cm2field, measured using a Farmer type chamber in solid water phantom.
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Figure 3c: Ionization depth dose curve for variable Gamma Putty thicknesses block with 18 MV photon beam at 10 × 10 cm2field, measured using a Farmer type chamber in solid water phantom.
Figure 4a: Attenuation of photon beam intensity with the variation of Gamma Putty block thickness for 6MV
Table 3: Half value and tenth value thickness for Gamma Putty blocksField size Energies6 MV 18 MVHVT (cm) TVT(cm) HVT(cm) TVT(cm)10X10 2.501 8.312 2.840 9.4369X9 2.739 9.101 2.899 9.6348X8 2.484 8.253 2.875 9.5547x7 2.475 8.223 2.851 9.4736X6 2.466 8.194 2.840 9.4345X5 2.466 8.194 2.840 9.4344X4 2.448 8.136 2.828 9.396Mean ± std 2.513±0.101 8.350±0.337 2.855±0.024 9.487±0.081C.V (%) 4.00 4.00 0.80 0.80
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Figure 4b: Attenuation of photon beam intensity with the variation of Gamma Putty block thickness for 18 MV photons.
Figure 5a: Off-axis relative dose profile at a depth of 0.5 cm for a 10 x 10 cm2 field size at 6 MV and 100 cm SSD
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Figure 5b: Off-axis relative dose profile at a depth of 0.5 cm for a 10 x 10 cm2 field size at 18 MV and 100 cm SSD
Figure 6a: Surface dose as a GPTF at 0 mm depth for 18 and 6 MV beam. GPTF is shown as a function of the Gamma Puttythickness.
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Figure 6b: Surface dose as a GPTF at 5 mm depth for 18 and 6 MV beam. GPTF is shown as a function of the Gamma Puttythickness.
Figure 6c: Surface dose as a GPTF at 10 cm depth for 18 and 6 MV beam. GPTF is shown as a function of the Gamma Puttythickness.
3.4. Surface doseSurface dose is usually defined as percent depth dose at0.5 mm depth, with normalization to dmax. Similarly to ablock tray, Gamma Putty increases skin dose. The effectis stronger with increasing field size and decreasingGamma Putty thickness. Skin dose values with theGamma Putty block were higher than those with an openfield by comparing GPTF of Figures 6a, b, and c. Theeffect was dominant in larger field sizes as the GammaPutty eliminates electrons from upstream and generatesnew secondary electrons by itself.15 These results in
higher number of electrons created than eliminated. Inaddition, secondary electrons initiated at the GammaPutty can reach the patient, thus increasing the skindose more significantly. The effect is exacerbated fromthe upper and lower windows in addition to the impactof SSD, field size, and energy. Figures 6b and c shows themeasured surface dose as a function of GPTF taken at 5mm depth. The surface dose decreases with GammaPutty thickness due to the beam hardening effect. Thereduction is about 6%, 14.5%, 22%, 36.37%, and 54%,
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for 6 MV and 2.75 %, 9.36%, 16.2%, 28.95%, and44.47% for 18 MV for Gamma Putty thicknesses of 0.3,0.5, 1.0, 1.5, 2.0, and 2.5 cm, respectively. Thisdemonstrates the impact of beam hardening on thesurface dose. All these factors enumerated above such ascontaminant electrons generated by the collimator,interactions of photons with Gamma Putty,self-absorption of Gamma Putty played a major role indose summation. However, at 10 cm depth interestinglyenough, GPTF does not get closer to unity. Hence, forsmall field size, photons and electrons are scattered outof the field when they pass though the Gamma Putty.Beyond dmax, the factor nearly remains constant.
4. ConclusionIn this report, Gamma Putty shielding effect on themegavoltage photon beam output has been analyzed forF18 and 6 MV. The result showed that severalparameters are responsible for fluctuation of dosereceived by a point in air blocked by a Gamma Putty.They included: field size, thickness of the attenuator, andbeam energy. The impact of these parameters isheightened by electrons contamination with increasingfield sizes and beam energy. In addition, themeasurement showed that GPTF values decreased withincreasing field size, depth, and thickness as beamhardening and more scatter for larger field sizescontributed to dose at the given depth. The studyrevealed that the dose outside the field are governed bythe skin collimation stopping the electrons in theincident beam due to the presence of the Gamma Puttyshielding and increased lateral scatter of the photonbeam as the Gamma Putty thickness is increased.Furthermore, the study suggested that contaminantelectrons to be a major factor of dose outside the field atshallow depths. The magnitude and extent increasedwith beam energy, even more in the presence of beammodifiers. In general, the primary dose rate at shallowdepths in the phantom may actually increase atdistances away from the CAX due flattening filter effectson the radiation beam.16,17Regarding the results, the percent ionization depth dosewas measured in solid water with broad beam geometry.Solid Water is convenient as it eliminates transport,rigorous set-up, and water filling tanks. However, theuncertainties budget for the measurement includedifference of stopping power of solid water that amountto 4% less than that of water between 10 keV and 50MeV,18 temperature differential between treatmentrooms and solid water, and several corrections factorsderived from temperature and pressure, ion chamber,electrometer, and absolute calibration. In addition,systematic error from set-up including tight fit for ionchamber, thermal equilibrium with the temperature inthe cavity, and acrylic holder may play a major role inthe data collected. Finally, the need to maintain aconsistency with regard to compressibility and pressure
in the confection of the Gamma Putty samples need to beexplored.
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